Anderson Energy Ltd. (AXLFF) Financials Nov 14, 2014, 8:10
Anderson Energy Ltd. (AXLFF) Financials Nov 14, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Anderson Energy Ltd.
Fiscal year is January-December. All values CAD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 68.74M 77.45M 104.49M 69.82M 48.85M
Cost of Goods Sold (COGS) incl. D&A 107.85M 110.41M 84.09M 69.7M 46.04M
COGS excluding D&A 26.91M 29.15M 29.53M 24.24M 17.32M
Depreciation & Amortization Expense 80.94M 81.27M 54.56M 45.46M 28.72M
Depreciation 80.94M 81.27M 54.56M 45.46M 28.72M
Amortization of Intangibles 0 0 0 0 0
Gross Income (39.11M) (32.97M) 20.39M 112,000 2.81M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 8.09M 8.91M 12.03M 10.42M 7.38M
Research & Development - 0 0 0 0
Other SG&A 8.09M 8.91M 12.03M 10.42M 7.38M
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 1.92M 31.93M 22.48M 43.63M
EBIT after Unusual Expense 0 (1.92M) (31.93M) (22.48M) (43.63M)
Non Operating Income/Expense 0 (131,000) 4.04M 4.66M (2.03M)
Non-Operating Interest Income 155,000 96,000 84,000 49,000 164,000
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 3.73M 3.35M 10.27M 13.65M 11.91M
Gross Interest Expense 3.73M 3.35M 10.27M 13.65M 11.91M
Interest Capitalized - - 0 0 0
Pretax Income (50.77M) (47.18M) (29.71M) (41.74M) (61.97M)
Income Tax (14.32M) (11.55M) (7.26M) (10.25M) 43.63M
Income Tax - Current Domestic 0 - 0 0 0
Income Tax - Current Foreign 0 0 0 0 0
Income Tax - Deferred Domestic (14.32M) 0 (7.26M) (10.25M) 43.63M
Income Tax - Deferred Foreign 0 0 0 0 0
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) - - - 0 0
Consolidated Net Income (36.46M) (35.63M) (22.44M) (31.49M) (105.6M)
Minority Interest Expense 0 0 0 0 0
Net Income (36.46M) (35.63M) (22.44M) (31.49M) (105.6M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (36.46M) (35.63M) (22.44M) (31.49M) (105.6M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (36.46M) (35.63M) (22.44M) (31.49M) (105.6M)
EPS (Basic) (0.29) (0.21) (0.13) (0.18) (0.61)
Basic Shares Outstanding 125.05M 170.3M 172.54M 172.55M 172.55M
EPS (Diluted) (0.29) (0.21) (0.13) (0.18) (0.61)
Diluted Shares Outstanding 125.05M 170.3M 172.54M 172.55M 172.55M
EBITDA 33.74M 39.39M 62.92M 35.15M 24.15M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...
Continue Reading
Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...
Continue Reading
The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...
Continue Reading
Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...
Continue Reading
Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...
Continue Reading
Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....
Continue Reading
Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...
Continue Reading
Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...
Continue Reading
Everyone wants a cozy, energy-efficient home, right? Well, the first step to achieving that might just surprise you. Forget about shoving more insulation into the walls for a second; air sealing should be your starting line. That's the drum Insulation Expert Mike Mancuso is beating, and he's got a point worth considering before you touch another insulation panel. Cracking...
Continue Reading
Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...
Continue Reading
Top 5 Most Recently Viewed Articles
MemorialCare Hospitals Shine in Women's Choice Awards MemorialCare has been recognized for its excellence in patient care through the Women's Choice Awards. The Long Beach Medical Center, Orange Coast Medical Center, and Saddleback Medical Center all received accolades for their exceptional clinical performance and patient satisfaction. These awards highlight the...
Continue Reading
Introducing UpAssist™ by InLine Aviation Group InLine Aviation Group has launched UpAssist™, a groundbreaking program designed to revolutionize supplemental maintenance for general aviation aircraft. This comprehensive offering goes beyond mere assistance; it integrates worldwide Aircraft on Ground (AOG) support, parts procurement, and 24/7 technical help. It also...
Continue Reading
Key Information About Bluefield Solar Income Fund Ltd Bluefield Solar Income Fund Ltd is in the spotlight as Rathbones Group Plc discloses significant ownership information pertaining to public securities. The importance of disclosure in maintaining transparency in financial markets cannot be overstated. Owner and Controller of Interests Rathbones Group Plc is recognized...
Continue Reading
New Tariffs on Imports from Mexico and the EU The United States has recently implemented significant tariffs on imports from Mexico and the European Union. This decision arises from longstanding trade imbalances and issues regarding narcotics trafficking. Details of the Recent Announcement Communication was sent from President Donald Trump to the leaders of Mexico and the...
Continue Reading
Webroot Secure VPN: A Leading Tool for Privacy and Security In today's digital age, the focus on online security has never been more paramount. With an increase in remote work, online shopping, and collaborative projects, the need for reliable protection is a top priority. Webroot Secure VPN emerges as a frontrunner in providing a safe browsing experience while ensuring...
Continue Reading